Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-30

Clinical Trial Update: Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects [Phase 1, Phase 2]

View source ↗

Summary

RN0361 is being studied in healthy adults and adults with hypertriglyceridemia (including familial chylomicronemia syndrome) in Phase 1 and Phase 2 trials; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RN0361

Snippet

Sponsor: Ikaria Bioscience Pty Ltd | Conditions: Hypertriglyceridemia, Familial Chylomicronemia Syndrome | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING